Report cover image

Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Growth (Status and Outlook) 2023-2029

Publisher LP Information, Inc.
Published Dec 05, 2023
Length 101 Pages
SKU # LPI18359460

Description

Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Growth (Status and Outlook) 2023-2029


The global Pharmaceutical Contract Sales Outsourcing (CSO) market size is projected to grow from US$ xx million in 2023 to US$ xx million in 2029; it is expected to grow at a CAGR of xx% from 2023 to 2029.
LPI (LP Information)' newest research report, the “Pharmaceutical Contract Sales Outsourcing (CSO) Industry Forecast” looks at past sales and reviews total world Pharmaceutical Contract Sales Outsourcing (CSO) sales in 2022, providing a comprehensive analysis by region and market sector of projected Pharmaceutical Contract Sales Outsourcing (CSO) sales for 2023 through 2029. With Pharmaceutical Contract Sales Outsourcing (CSO) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharmaceutical Contract Sales Outsourcing (CSO) industry.
This Insight Report provides a comprehensive analysis of the global Pharmaceutical Contract Sales Outsourcing (CSO) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pharmaceutical Contract Sales Outsourcing (CSO) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pharmaceutical Contract Sales Outsourcing (CSO) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharmaceutical Contract Sales Outsourcing (CSO) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharmaceutical Contract Sales Outsourcing (CSO).
United States market for Pharmaceutical Contract Sales Outsourcing (CSO) is estimated to increase from US$ xx million in 2022 to US$ xx million by 2029, at a CAGR of xx% from 2023 through 2029.

China market for Pharmaceutical Contract Sales Outsourcing (CSO) is estimated to increase from US$ xx million in 2022 to US$ xx million by 2029, at a CAGR of xx% from 2023 through 2029.
Europe market for Pharmaceutical Contract Sales Outsourcing (CSO) is estimated to increase from US$ xx million in 2022 to US$ xx million by 2029, at a CAGR of xx% from 2023 through 2029.
Global key Pharmaceutical Contract Sales Outsourcing (CSO) players cover China Medical System (CMS), IQVIA, PHOENIX Group, and EVERSANA, etc. In terms of revenue, the global two largest companies occupied for a share nearly XX% in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical Contract Sales Outsourcing (CSO) market by product type, application, key players and key regions and countries.
Segmentation by type
Cardiovascular Disorders
Oncology
Metabolic Disorders
Neurology
Others

Segmentation by application
Hospital
Clinic
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
China Medical System (CMS)
IQVIA
PHOENIX Group
EVERSANA
Ashfield Engage (Inizio)
Amplity Health
Sinco Pharma
Syneos Health
EPS Corporation
Uniphar Group
CMIC Group
SciClone Pharmaceuticals
China Pioneer Pharma
Promoveo Health
CSO Pharmitalia
GTS Solution
QFR Solutions

Please note: The report will take approximately 2 business days to prepare and deliver.

Table of Contents

101 Pages
*This is a tentative TOC and the final deliverable is subject to change.*
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Size 2018-2029
2.1.2 Pharmaceutical Contract Sales Outsourcing (CSO) Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Pharmaceutical Contract Sales Outsourcing (CSO) Segment by Type
2.2.1 Cardiovascular Disorders
2.2.2 Oncology
2.2.3 Metabolic Disorders
2.2.4 Neurology
2.2.5 Others
2.3 Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Type
2.3.1 Pharmaceutical Contract Sales Outsourcing (CSO) Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Size Market Share by Type (2018-2023)
2.4 Pharmaceutical Contract Sales Outsourcing (CSO) Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Application
2.5.1 Pharmaceutical Contract Sales Outsourcing (CSO) Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Size Market Share by Application (2018-2023)
3 Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Player
3.1 Pharmaceutical Contract Sales Outsourcing (CSO) Market Size Market Share by Players
3.1.1 Global Pharmaceutical Contract Sales Outsourcing (CSO) Revenue by Players (2018-2023)
3.1.2 Global Pharmaceutical Contract Sales Outsourcing (CSO) Revenue Market Share by Players (2018-2023)
3.2 Global Pharmaceutical Contract Sales Outsourcing (CSO) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Pharmaceutical Contract Sales Outsourcing (CSO) by Regions
4.1 Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Regions (2018-2023)
4.2 Americas Pharmaceutical Contract Sales Outsourcing (CSO) Market Size Growth (2018-2023)
4.3 APAC Pharmaceutical Contract Sales Outsourcing (CSO) Market Size Growth (2018-2023)
4.4 Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Size Growth (2018-2023)
4.5 Middle East & Africa Pharmaceutical Contract Sales Outsourcing (CSO) Market Size Growth (2018-2023)
5 Americas
5.1 Americas Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Country (2018-2023)
5.2 Americas Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Type (2018-2023)
5.3 Americas Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Region (2018-2023)
6.2 APAC Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Type (2018-2023)
6.3 APAC Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Pharmaceutical Contract Sales Outsourcing (CSO) by Country (2018-2023)
7.2 Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Type (2018-2023)
7.3 Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pharmaceutical Contract Sales Outsourcing (CSO) by Region (2018-2023)
8.2 Middle East & Africa Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Type (2018-2023)
8.3 Middle East & Africa Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Forecast
10.1 Global Pharmaceutical Contract Sales Outsourcing (CSO) Forecast by Regions (2024-2029)
10.1.1 Global Pharmaceutical Contract Sales Outsourcing (CSO) Forecast by Regions (2024-2029)
10.1.2 Americas Pharmaceutical Contract Sales Outsourcing (CSO) Forecast
10.1.3 APAC Pharmaceutical Contract Sales Outsourcing (CSO) Forecast
10.1.4 Europe Pharmaceutical Contract Sales Outsourcing (CSO) Forecast
10.1.5 Middle East & Africa Pharmaceutical Contract Sales Outsourcing (CSO) Forecast
10.2 Americas Pharmaceutical Contract Sales Outsourcing (CSO) Forecast by Country (2024-2029)
10.2.1 United States Pharmaceutical Contract Sales Outsourcing (CSO) Market Forecast
10.2.2 Canada Pharmaceutical Contract Sales Outsourcing (CSO) Market Forecast
10.2.3 Mexico Pharmaceutical Contract Sales Outsourcing (CSO) Market Forecast
10.2.4 Brazil Pharmaceutical Contract Sales Outsourcing (CSO) Market Forecast
10.3 APAC Pharmaceutical Contract Sales Outsourcing (CSO) Forecast by Region (2024-2029)
10.3.1 China Pharmaceutical Contract Sales Outsourcing (CSO) Market Forecast
10.3.2 Japan Pharmaceutical Contract Sales Outsourcing (CSO) Market Forecast
10.3.3 Korea Pharmaceutical Contract Sales Outsourcing (CSO) Market Forecast
10.3.4 Southeast Asia Pharmaceutical Contract Sales Outsourcing (CSO) Market Forecast
10.3.5 India Pharmaceutical Contract Sales Outsourcing (CSO) Market Forecast
10.3.6 Australia Pharmaceutical Contract Sales Outsourcing (CSO) Market Forecast
10.4 Europe Pharmaceutical Contract Sales Outsourcing (CSO) Forecast by Country (2024-2029)
10.4.1 Germany Pharmaceutical Contract Sales Outsourcing (CSO) Market Forecast
10.4.2 France Pharmaceutical Contract Sales Outsourcing (CSO) Market Forecast
10.4.3 UK Pharmaceutical Contract Sales Outsourcing (CSO) Market Forecast
10.4.4 Italy Pharmaceutical Contract Sales Outsourcing (CSO) Market Forecast
10.4.5 Russia Pharmaceutical Contract Sales Outsourcing (CSO) Market Forecast
10.5 Middle East & Africa Pharmaceutical Contract Sales Outsourcing (CSO) Forecast by Region (2024-2029)
10.5.1 Egypt Pharmaceutical Contract Sales Outsourcing (CSO) Market Forecast
10.5.2 South Africa Pharmaceutical Contract Sales Outsourcing (CSO) Market Forecast
10.5.3 Israel Pharmaceutical Contract Sales Outsourcing (CSO) Market Forecast
10.5.4 Turkey Pharmaceutical Contract Sales Outsourcing (CSO) Market Forecast
10.5.5 GCC Countries Pharmaceutical Contract Sales Outsourcing (CSO) Market Forecast
10.6 Global Pharmaceutical Contract Sales Outsourcing (CSO) Forecast by Type (2024-2029)
10.7 Global Pharmaceutical Contract Sales Outsourcing (CSO) Forecast by Application (2024-2029)
11 Key Players Analysis
11.1 China Medical System (CMS)
11.1.1 China Medical System (CMS) Company Information
11.1.2 China Medical System (CMS) Pharmaceutical Contract Sales Outsourcing (CSO) Product Offered
11.1.3 China Medical System (CMS) Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 China Medical System (CMS) Main Business Overview
11.1.5 China Medical System (CMS) Latest Developments
11.2 IQVIA
11.2.1 IQVIA Company Information
11.2.2 IQVIA Pharmaceutical Contract Sales Outsourcing (CSO) Product Offered
11.2.3 IQVIA Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 IQVIA Main Business Overview
11.2.5 IQVIA Latest Developments
11.3 PHOENIX Group
11.3.1 PHOENIX Group Company Information
11.3.2 PHOENIX Group Pharmaceutical Contract Sales Outsourcing (CSO) Product Offered
11.3.3 PHOENIX Group Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 PHOENIX Group Main Business Overview
11.3.5 PHOENIX Group Latest Developments
11.4 EVERSANA
11.4.1 EVERSANA Company Information
11.4.2 EVERSANA Pharmaceutical Contract Sales Outsourcing (CSO) Product Offered
11.4.3 EVERSANA Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 EVERSANA Main Business Overview
11.4.5 EVERSANA Latest Developments
11.5 Ashfield Engage (Inizio)
11.5.1 Ashfield Engage (Inizio) Company Information
11.5.2 Ashfield Engage (Inizio) Pharmaceutical Contract Sales Outsourcing (CSO) Product Offered
11.5.3 Ashfield Engage (Inizio) Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Ashfield Engage (Inizio) Main Business Overview
11.5.5 Ashfield Engage (Inizio) Latest Developments
11.6 Amplity Health
11.6.1 Amplity Health Company Information
11.6.2 Amplity Health Pharmaceutical Contract Sales Outsourcing (CSO) Product Offered
11.6.3 Amplity Health Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Amplity Health Main Business Overview
11.6.5 Amplity Health Latest Developments
11.7 Sinco Pharma
11.7.1 Sinco Pharma Company Information
11.7.2 Sinco Pharma Pharmaceutical Contract Sales Outsourcing (CSO) Product Offered
11.7.3 Sinco Pharma Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Sinco Pharma Main Business Overview
11.7.5 Sinco Pharma Latest Developments
11.8 Syneos Health
11.8.1 Syneos Health Company Information
11.8.2 Syneos Health Pharmaceutical Contract Sales Outsourcing (CSO) Product Offered
11.8.3 Syneos Health Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Syneos Health Main Business Overview
11.8.5 Syneos Health Latest Developments
11.9 EPS Corporation
11.9.1 EPS Corporation Company Information
11.9.2 EPS Corporation Pharmaceutical Contract Sales Outsourcing (CSO) Product Offered
11.9.3 EPS Corporation Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 EPS Corporation Main Business Overview
11.9.5 EPS Corporation Latest Developments
11.10 Uniphar Group
11.10.1 Uniphar Group Company Information
11.10.2 Uniphar Group Pharmaceutical Contract Sales Outsourcing (CSO) Product Offered
11.10.3 Uniphar Group Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Uniphar Group Main Business Overview
11.10.5 Uniphar Group Latest Developments
11.11 CMIC Group
11.11.1 CMIC Group Company Information
11.11.2 CMIC Group Pharmaceutical Contract Sales Outsourcing (CSO) Product Offered
11.11.3 CMIC Group Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 CMIC Group Main Business Overview
11.11.5 CMIC Group Latest Developments
11.12 SciClone Pharmaceuticals
11.12.1 SciClone Pharmaceuticals Company Information
11.12.2 SciClone Pharmaceuticals Pharmaceutical Contract Sales Outsourcing (CSO) Product Offered
11.12.3 SciClone Pharmaceuticals Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 SciClone Pharmaceuticals Main Business Overview
11.12.5 SciClone Pharmaceuticals Latest Developments
11.13 China Pioneer Pharma
11.13.1 China Pioneer Pharma Company Information
11.13.2 China Pioneer Pharma Pharmaceutical Contract Sales Outsourcing (CSO) Product Offered
11.13.3 China Pioneer Pharma Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 China Pioneer Pharma Main Business Overview
11.13.5 China Pioneer Pharma Latest Developments
11.14 Promoveo Health
11.14.1 Promoveo Health Company Information
11.14.2 Promoveo Health Pharmaceutical Contract Sales Outsourcing (CSO) Product Offered
11.14.3 Promoveo Health Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Promoveo Health Main Business Overview
11.14.5 Promoveo Health Latest Developments
11.15 CSO Pharmitalia
11.15.1 CSO Pharmitalia Company Information
11.15.2 CSO Pharmitalia Pharmaceutical Contract Sales Outsourcing (CSO) Product Offered
11.15.3 CSO Pharmitalia Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 CSO Pharmitalia Main Business Overview
11.15.5 CSO Pharmitalia Latest Developments
11.16 GTS Solution
11.16.1 GTS Solution Company Information
11.16.2 GTS Solution Pharmaceutical Contract Sales Outsourcing (CSO) Product Offered
11.16.3 GTS Solution Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 GTS Solution Main Business Overview
11.16.5 GTS Solution Latest Developments
11.17 QFR Solutions
11.17.1 QFR Solutions Company Information
11.17.2 QFR Solutions Pharmaceutical Contract Sales Outsourcing (CSO) Product Offered
11.17.3 QFR Solutions Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 QFR Solutions Main Business Overview
11.17.5 QFR Solutions Latest Developments
12 Research Findings and Conclusion

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us